New partnership will bring Everspin 256Mb PERSYST MRAM into Teledyne HiRel Semiconductors’ memory solutions for mission-critical systems Everspin Technologies, Inc. (NASDAQ:MRAM), the world’s leading developer and manufacturer of MRAM solutions, and Teledyne HiRel Semiconductors (Teledyne HiRel), a business unit of Teledyne Technologies Incorporated (NYSE:TDY) and a leading supplier of high-reliability semiconductor solutions, today announced a strategic partnership to accelerate adoption of Everspin’s MRAM in aerospace, defense and other demanding systems. This collaboration will begin with the 256Mb PERSYST spin-transfer torque MRAM (STT-MRAM), a non-volatile memory that combines RAM-li
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Everspin Technologies and Teledyne HiRel Semiconductors Partner to Accelerate MRAM Adoption in Aerospace and Defense Applications
- New IBM Study Finds AI Adoption Is Outpacing K-12 Readiness
National survey finds AI readiness gap in schools as IBM launches the IBM K-12 AI leaders fellowship for district leaders to support responsible AI adoptionNEW YORK, Sept. 2, 2026 /PRNewswire/ -- IBM (NYSE:IBM) today announced new U.S. research examining AI readiness in K-12 schools and the launch of the IBM K-12 AI leaders fellowship. As schools begin a new academic year, AI is becoming a routine part of K-12 teaching and learning. Yet the survey*, commissioned by IBM and conducted by Morning Consult, finds that the systems supporting responsible AI use are still catching up, pointing to a gap between how quickly AI is enterin
- Cardinal Infrastructure Group Company, ALGC, Announces Contract Win on Walmart Sorting Facility
RALEIGH, N.C., Sept. 2, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (NASDAQ:CDNL) ("Cardinal" or the "Company"), announced today that A.L. Grading Contractors (ALGC) has been awarded an approximately $40 million contract to deliver full-site civil infrastructure services for the Carnesville, Georgia, Walmart Sorting Facility. The 164-acre project will be self-performed by ALGC and Allied Paving Contractors, Cardinal's previously announced paving company acquisition expected to close in the fourth quarter. The scope of work includes mass grading of 1.8 million cubic yards; 54,000 linear feet of storm, sewer and wate
- OpenPayd Strengthens Position in the U.S. Market Through the Acquisition of 43 State Licences
Secures extensive U.S. market access for global clients through the addition of 43 state Money Transmitter Licences ("MTLs") under the OpenPayd umbrella through integration of MSB USA Inc. Follows landmark quarter of growth across clients, payments volumes and revenue Solidifies global client offering ahead of OpenPayd’s planned listing on the Nasdaq OpenPayd, a leading provider of financial infrastructure, has announced a significant expansion of its regulatory footprint into the United States, positioning the company for accelerated growth in the critical North American market. The strategic expansion will see the integration of MSB USA Inc. ("MSB USA"), a U.S.-based, state-li
- United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis
Nebulized Tyvaso® (treprostinil) Inhalation Solution will be the first and only inhaled anti-fibrotic treatment for idiopathic pulmonary fibrosis (IPF) if approved by the U.S. Food and Drug Administration (FDA) United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the FDA has accepted the supplemental New Drug Application (sNDA) for nebulized Tyvaso® (treprostinil) Inhalation Solution to treat IPF. United Therapeutics anticipates the agency's review to be complete in late April 2027. Nebulized Tyvaso has not been approved by the FDA for IPF and remains investigational for this indication. "Nebulized Tyvaso combines direct lung delivery with m
- Rapport Therapeutics to Participate in Upcoming Investor Conferences
BOSTON and SAN DIEGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (NASDAQ:RAPP) ("Rapport" or the "Company"), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that management plans to participate in the following upcoming investor events: Cantor Global Healthcare Conference (New York City) – fireside chat on Wednesday, September 9, 2026, at 1:35-2:05 pm ET. TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit (virtual) – fireside chat on Wednesday, September 23, 2026, at 1:30-1:55 pm ET. Interested parties may access
- By Popular Demand: Tilray Beverages Makes Popsicle Hard Firecracker a Permanent Flavor
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, in partnership with The Magnum Ice Cream Company, today announced that Popsicle Hard Firecracker will transition to a permanent, year-round flavor in the Popsicle Hard portfolio, following an overwhelmingly positive response from consumers. Originally introduced as a limited-edition seasonal flavor, Firecracker quickly became a fan favorite. Inspired by one of Popsicle’s most recognizable frozen treats, the flavor captures the classic red, white and blue combination of cherry, lemon-lime and blue raspberry notes. Following i
- Arrow Electronics broadens HPE offerings, adding complete HPE Networking portfolio in North America and EMEA
Expanded offerings enable channel partners to deliver end-to-end networking, hybrid cloud, AI, and infrastructure solutions with greater simplicity and scale. Arrow Electronics, Inc. (NYSE:ARW) today announced it has been awarded distribution rights for the HPE Networking product portfolio across North America and select EMEA countries1. The addition expands Arrow's ability to provide channel partners with the complete HPE portfolio, including HPE Aruba Networking and HPE Juniper Networking solutions. The expansion gives channel partners access to a comprehensive set of solutions spanning campus, data center, cloud-managed networking, and AI-native infrastructure. It also strengthens Ar
- Solaris Energy Infrastructure Acquires Omega, Adding Specialized EPC Capabilities to Its Power Infrastructure Offering
Solaris Energy Infrastructure, Inc. (NYSE:SEI) ("Solaris" or the "Company"), today announced the acquisition of Omega Foundation Services ("Omega"), a leader in the specialized engineering, procurement and construction ("EPC") industry with significant expertise in heavy civil construction across multiple end markets, including large-scale data centers. Transaction Strategy and Highlights Expands Turnkey Execution Capabilities. Adds to the Company’s full-cycle power solutions, which now include early-stage site services, front-end plant installation & commissioning services and electrical substation development. Addresses Key Industry Bottleneck. Brings in-house a large team of skil
- GeoCue Elevates Survey-Grade Drone Mapping with Ouster's BABA-Compliant Native Color Rev8 Digital Lidar
Pairing survey-grade precision with Ouster’s 256-channel Rev8 OS1 Max lidar, GeoCue’s latest TrueView lineup sets a new benchmark for U.S. drone surveying Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, announced a strategic partnership with GeoCue, a premier provider of drone mapping payloads and software, to integrate Ouster’s native color Rev8 OS1 Max digital lidar into GeoCue’s TrueView product line. The collaboration pairs GeoCue's TrueView 1 payloads and LP360 software with Ouster's digital lidar to deliver survey-grade data to the utility and infrastructure industries. This press release features multimedia. View the full
- GXO Announces Participation in Upcoming Investor Conferences
GREENWICH, Conn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE:GXO), the world’s largest pure-play contract logistics provider, today announced that company leaders will present at the following investor conferences: Jefferies Global Industrials ConferencePresenters: Chief Executive Officer Patrick Kelleher and Chief Strategy Officer Kristine KubackiDetails: Wednesday, September 9, 2026, at 8:50AM ET in New York CityWebcast information will be posted to the Company’s Investor Relations website. Morgan Stanley 14th Annual Laguna ConferencePresenters: Chief Financial Officer Mark Suchinski and Chief Strategy Officer Kristine KubackiDetails: Wednesday, September 16, 2026, at
- Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
FOSTER CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences. Cantor 2026 Global Healthcare Conference in New York, NY on Wednesday, September 9, 2026, with a fireside chat at 1.35pm ET (link here).H.C. Wainwright 28th Annual Global Investment Conference in New York, NY on Monday, September 14, 2026. The fireside chat will be available in the Investors & Media section of Sagimet’s website at www.sagimet.com, with an archived replay available
- Nebius to participate in upcoming investor conferences
Nebius Group N.V. (("Nebius Group" or the "Company", NASDAQ:NBIS), the AI cloud company, today announced that members of its management team will take part in the following investor conferences: Goldman Sachs Communacopia + Technology Conference on September 8, 2026 at 3:45 PM (PT). Citi’s 2026 Global TMT Conference on September 9, 2026 at 7:50 AM (PT). The registration link to the live webcast and a replay of each event will be available on the company’s investor relations website at https://nebius.com/investor-hub. About Nebius Nebius, the AI cloud company, is building the full-stack platform for developers and companies to take charge of their AI future — from data and model
- Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (NASDAQ:LXEO) a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that members of management will participate in the following investor conferences in September: Cantor Global Healthcare Conference 2026. Fireside chat on Wednesday, September 9, 2026 at 2:10 p.m. ET in New York, NY. Baird 2026 Global Healthcare Conference. Fireside chat on Tuesday, September 15, 2026 at 11:25 a.m. ET in New York, NY. The events will be webcast live under the Events & Presentations tab in the Investors section of the Company’s website. A replay of the webcasts w
- Aeluma to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on September 16, 2026
GOLETA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ:ALMU), a semiconductor company specializing in high-performance, scalable technologies for mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum, today announced it will issue its financial results for the fourth quarter and full year of fiscal 2026, which ended June 30, 2026, after the U.S. financial markets close on Wednesday, September 16, 2026. That same day, Aeluma will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss the Company’s financial results and business outlook. Interested participants may access the conference call by dialing (877) 317-6789 (dome
- Maze Therapeutics to Participate in Three Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (NASDAQ:MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced that company management will participate in three upcoming investor conferences: Wells Fargo 21st Annual Healthcare Conference; fireside chat on Wednesday, September 9, 2026, at 9:30 a.m. ETCiti 2026 Biopharma Back to School Summit; fireside chat on Thursday, September 10, 2026, at 2:20 p.m. ETH.C. Wainwright 28th Annual Global Investment Conference; fireside chat on Tuesday, September 15, 2026, at 9:00 a.m. ET Live webcasts of the eve
- Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences
Topline data from Phase 1/2 Cohort 1 of OPGx-BEST1 gene therapy program to be presented during investor conference call and webcast on September 9 at 8:00 a.m. ET Full clinical dataset and additional analyses evaluating key measures of visual function to be presented at upcoming medical meetings RESEARCH TRIANGLE PARK, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. ("Opus" or the "Company"), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced plans to present topline clinical data from Cohort 1 of its Phase 1/2 study of OPGx-BEST1 during an investor c
- Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
Highlights Fortrea enters into a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical TrialsIncludes a 60,000 sq. ft. GLP bioanalytical lab in Austin; a 200-bed GCP-compliant clinical pharmacology unit in San Antonio; and a biospecimen storage facility in Pflugerville, TexasEnables integrated execution of early-phase studies with large and small molecule bioanalytical capabilities, enhancing Fortrea’s ability to deliver faster, more integrated early clinical development solutions for simple and complex clinical studiesStrengthens Fortrea’s end-to-end clinical development platform, supporting customers from first-in-human studies through Phase IV and post-a
- MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference YAVNE, Israel, September 2, 2026 -- MediWound Ltd. (NASDAQ:MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that Ofer Gonen, Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference. The conference will take place September 14–16, 2026, at the Lotte New York Palace Hotel in New York City. The fireside chat, moderated by Swayampakula Ramakanth, Managing Director and Senior Healthcare Analyst at H.C. Wainwright, is scheduled for Monday, September 14, 2026, at 2:00 p.m. ET. A live webcast of
- WRAP Moves to Operationalize De-Escalation, Advances New BolaWrap 150 Doctrine Toward California POST Certification
MIAMI, Sept. 02, 2026 (GLOBE NEWSWIRE) -- WRAP Technologies, Inc. ("WRAP" or the "Company"), a global provider of public safety and defense technologies and training solutions, today announced the completion of a new law enforcement doctrine and training methodology designed to operationalize de-escalation using the BolaWrap® 150, an instrument of restraint and rescue that the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has classified as neither a firearm nor an "any other weapon." The new curriculum has been submitted for independent validation in preparation for applying for California Peace Officer Standards and Training (POST) certification, an important step toward esta